Skip to content

Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)

Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00201656
Acronym
PROMCerclage
Enrollment
58
Registered
2005-09-20
Start date
2004-11-30
Completion date
2014-04-30
Last updated
2014-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Membranes, Premature Rupture

Keywords

PPROM, Cerclage, Preterm Premature Rupture of the Membranes with Cerclage

Brief summary

The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

Detailed description

The placement of cervical cerclage is standard of care for women who experience incompetent cervix. Treadwell et al, published the largest retrospective review of 482 patients receiving cerclage (364 elective and 118 emergent). They found premature rupture of membranes (PROM) in 38% of the subjects with 9% delivering \<27 weeks. Preterm birth is the cause of at least 75% of neonatal deaths that are not due to congenital malformations. The question of whether to remove cerclage after preterm premature rupture of membranes (PPROM) is one of the unresolved controversies in obstetrics because the few available studies are retrospective, all have small numbers of patients, and the studies have given conflicting results regarding the safety of retaining a cerclage after preterm premature rupture of the membranes. It is unclear from the retrospective studies whether latency (the interval from membrane rupture to the onset of labor) is prolonged with retention of the suture. Furthermore, some, but not all studies suggest an increase in major infectious maternal morbidity and possibly neonatal morbidity. For this reason, clinicians vary greatly in deciding on whether to remove a cerclage in a patient with PPROM and either practice is currently an acceptable standard. This is a fairly rare complication, the combination of PPROM in a patient with cerclage in place only occurs in about 1-3/1000 pregnant women. Thus it has been impossible to study this problem prospectively in any single institution. The establishment of the Obstetrix Collaborative Research Group affords the unique opportunity to study this rare complication. Obstetrix manages 19 practices of Perinatologists around the U.S. and Mexico and is comprised of nearly 100 such subspecialists. This problem is most often referred to a Perinatologist when it occurs, so it is not unusual for these practices to see 5 - 10 such patients per year. Obstetrix fully funds the infrastructure of this research group and inclusion in this study will not alter the cost of patient care in either group as there is virtually no cost in removing the cerclage and all these patients are kept in hospital until delivery when membranes rupture as standard of care. This is a multicenter trial. The purpose is to determine whether retention of cerclage after preterm premature rupture of the membranes improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

Interventions

PROCEDURERetention of Cerclage

Retain Cerclage until clinical removal is indicated by protocol

PROCEDURERemoval of Cerclage

Immediate removal of Cerclage following randomization

PROCEDURERemoval vs. Retention of Cervical Cerclage

Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress

Sponsors

Obstetrix Medical Group
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. A previously placed prophylactic cerclage defined as any cerclage done \< 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation \< 3 cm 2. Spontaneous rupture of membranes 22-32 weeks 3. Singleton or twin gestation 4. Shirodkar or McDonald cerclage in place \> 1 week

Exclusion criteria

1. Active labor (\> 8 uterine contractions \[UCs\] per hour) 2. Chorioamnionitis as defined by temperature \> 38 plus fetal tachycardia or uterine tenderness 3. Placenta previa or undiagnosed vaginal bleeding 4. Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP) 5. Mature pulmonary studies 6. Positive gram stain, culture, white blood cells (WBC) \> 30, or glucose \< 14 on amniocentesis 7. Major fetal anomaly 8. Presentation \> 48 hours after rupture of membranes 9. abdominal cerclage 10. Cerclage done for symptomatic cervical dilation (cervix dilated \> 3 cm) 11. Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)

Design outcomes

Primary

MeasureTime frame
Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tendernessconception to birth
Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal deathBirth to 28days of life
Respiratory distress syndromebirth to 28days of life
Documented sepsis within 72 hours of deliverybirth to 72 hours after delivery
Grade 3 or 4 intraventricular hemorrhagebirth to 28days of life
Stage 2 or 3 necrotizing enterocolitisbirth to 28days of life
Neonatal intensive care unit (NICU) staybirth to 28days of life
Birth weightat birth
Estimated gestational age (EGA) at deliveryat delivery
Postpartum endometritisbirth to 28days of life
Maternal sepsisbirth to 28days following delivery
Latencylabor to delivery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026